Rise of the New Plagues III Mar 25, 2006 0:47:40 GMT -5
Post by Big Bunny on Mar 25, 2006 0:47:40 GMT -5
Although such microbes are still looked upon with disbelief by many bacteriologists, this pleomorphism is consistent with bacteria cultured and studied by various cancer microbe researchers over the past century. Busni's work showing acid-fast bacteria in HD was later confirmed by Aplas in a series of papers (1959-1963) in the German literature [13-14], and by Cantwell in 1982 [6-8].
The pleomorphic microbe of cancer cannot be easily "classified" because it defies the laws of microbiology. As stated, traditional microbiologists and pathologists do not believe in "life cycles" for bacteria.
The famous Russian microbiologist N A Krasilnikov, in his seminal book, Soil Microorganisms and Higher Plants, remarks about the classification of bacteria, particularly the "actinomycetes" (the bacteria-like and fungal-like microbes), to which the HD microbe (and the cancer microbe) is closely related. He writes:
The classification of microorganisms is very unsatisfactory. There is no common principle of classification in microbiology. The classification of bacteria and actinomycetes is especially inadequate. This can be explained by the peculiarity of those organisms, the simplicity of their structure and growth and lack of external properties for differentiation.
The bacteria of the genus Micrococcus are characterized by their spherical shape. Into this group organisms which in fact belong to coccoid bacteria are included and also not infrequently specimens of actinomycetes are included in the genus Mycococcus.
The shortcomings of the bacteriological classification have their origin in our scant knowledge of the life of the organisms. In order to be able to speak of the phylogenetic relations between the organisms, it is not sufficient to know and study one randomly chosen stage of the life cycle of the microbe. A thorough knowledge of its growth, development, structure, reproduction, life cycle, polymorphism, variability, etc, is needed. In order to obtain much knowledge, the organism in question should be studied not only in laboratory conditions but also in natural surroundings. (italics Cantwell)
The lack of knowledge of the life cycle of this or another microbe frequently misleads the investigator. For example for this reason mycobacteria are considered by some authors as micrococci or as rodlike bacteria.Krasinikov's full treatise is available free on-line in the Library section at www.soilandhealth.org.
Cancer, and the "Human-Bacteria Hybrid"
Most people do not envision the human body as immersed in a sea of microbes from internal and external sources. Our only protection from the trillions of potentially dangerous bacteria that inhabit our bodies is our immune system and the grace of God, for want of a better phrase.
There is also recent evidence that bacteria and human cells constantly "swap genes", much like the AIDS retrovirus swaps its genetic material with human cells. Rowan Hooper, writing in Wired News about new research at Imperial College London, notes: "Most of the cells in your body are not your own, nor are they even human. They are bacterial. From the invisible strands of fungi waiting to sprout between our toes, to the kilogram of bacterial matter in our guts, we are best viewed as walking 'superorganisms,' highly complex conglomerations of human cells, bacteria, fungi and viruses. More than 500 different species of bacteria exist in our bodies, making up more than 100 trillion cells. Because our bodies are made of only some several trillion human cells, we are somewhat outnumbered by the aliens. It follows that most of the genes in our bodies are from bacteria, too. Luckily for us, the bacteria are on the whole commensal, sharing our food but doing no real harm."
Some physicians might expect a cancer germ to be a specific kind and species of bacterium, but there is no reason why this should be the case. Physicians also expect an antibiotic (and radiation) to kill cancer bacteria, when, in fact, cancer bacteria cannot be eradicated so easily. Doctors expect a cancer germ to be present in cancer patients, but not in cancer-free patients. However, Virginia Livingston and others carefully noted that everyone carries cancer germs. This is not unlike the millions of healthy Americans who carry antibiotic-resistant staphylococci in the nose, the same bacteria that in other people can cause death-threatening infections unresponsive to any available antibiotic therapy. Or normal, healthy people who carry cancer-causing bacteria in the stomach.
I am aware of microbiologists and pathologists who demand "proof" that these round forms are microbes. However, I contend that after attending medical school physicians should be able to recognize bacteria when they see them. And surely these "forms" reported for a century should be recognized as significant and studied carefully. The disinterest of the medical and microbiologic community in investigating bacteria in HD and other forms cancer is not in the tradition of good science.
There is no longer any excuse to be ignorant of research pointing to bacteria as a possible cause of cancer, particularly when evidence of such bacteria resides in the medical literature. Previously, the contents of medical journals were closed to most people who could not gain entrance to a medical library. By use of Internet search engines and the PubMed website, published medical literature is now easily available to everyone via the click of a mouse.
A computer Internet search, using key words such as: cancer microbe, cancer bacteria, pleomorphism, and nanobacteria + cancer, provides a good introduction to the microbiology of cancer. In addition, I suggest Googling cancer research workers, such as Virginia Livingston, Erik Enby, Guenther Enderlein, Alan Cantwell, Lida Mattman, Wilhelm Reich + T Bacilli, Raymond Royal Rife, and others.
The cancer microbe has a rich history dating back to the nineteenth century. Anyone interested in the bacterial cause of cancer and certain other diseases of unknown etiology would be well advised to explore it.
1. Busni N. Uber die Verwantschaft der Mycosis fungoides und der Lymphogranulomatose. Darstellung von Mikroorganismen in Geweben bei experimentellan Granulomen. Virchow's Arch Pathol Anat. 1931; 280:627-639.
2. Busni N. Ein Beitrag zur Atiologie der Lymphogranulomatose. Virchow's Arch Pathol Anat. 1928;268:614-628
3. Wallhauser A. Hodgkin's disease. Arch Pathol. 1933; 16:522-562.
4. Stewart HL. Etiologic studies in Hodgkin's disease. J Lab Clin Med. 1932;18;281-287.
5. Steiner PE. Hodgkin's disease: search for an infective agent and attempts at experimental reproduction. Arch Pathol. 1934;17:749-763.
6. Cantwell AR. Variably acid-fast cell wall-deficient bacteria as a possible cause of dermatologic disease. In, Domingue GJ, editor. Cell Wall Deficient Bacteria. Reading: Addison-Wesley Publishing Co; 1982. pp. 321-360.
7. Cantwell AR. Histologic observations of variably acid-fast coccoid forms suggestive of cell wall deficient bacteria in Hodgkin's disease: a report of four cases. Growth. 1981 Autumn;45(3):168-87.
8. Cantwell AR Jr, Kelso DW. Variably acid-fast bacteria in a fatal case of Hodgkin's disease. Arch Dermatol. 1984 Mar;120(3):401-2.
9. Centkowski P, Sawczuk-Chabin J, Prochorec M, Warzocha K. Hodgkin's lymphoma and tuberculosis coexistence in cervical lymph nodes. Leuk Lymphoma. 2005 Mar;46(3):471-5.
10. de Hemricourt E, De Boeck K, Hilte F, Abib A, Kockx M, Vandevivere J, De Bock R. Sarcoidosis and sarcoid-like reaction following Hodgkin's disease. Report of two cases. Mol Imaging Biol. 2003 Jan-Feb;5(1):15-9.
11. Jaffe ES, Zarate-Osorno A, Kingma DW, Raffeld M, Medeiros LJ. The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas. Ann Oncol. 1994;5 Suppl 1:7-11.
12. Park CS, Chung HC, Lim HY, Kim DL, Koh EH, Kim JH, Roh JK, Chun SI, Yang WI, Kim GE, et al. Coexisting mycosis fungoides and Hodgkin's disease as a composite lymphoma: a case report. Yonsei Med J. 1991 Dec;32(4):362-9.
13. Aplas V. Tierexperimentelle Untersuchungun zur Virusatiologie der Mycosis fungoides. Archiv Klin Exp Dermatol. 1963; 205:272-281.
14. Aplas V. Weiterer Beitrag sur Atiologie der Mycosis fungoides. Arch Klin Exp Dermatol. 1963; 216:63-70.
15. Cantwell AR. Variably acid-fast pleomorphic bacteria as a possible cause of mycosis fungoides: a report of a necropsied case and two living patients. J Dermatol Surg Oncol. 1982 Mar;8(3):203-
16. Cantwell AR. Variably acid-fast bacteria in a rare case of coexistent malignant lymphoma and cutaneous sarcoid-like granulomas. Int J Dermatol. 1982 Mar;21(2):99-106.
17. Pescarmona E, Pignoloni P, Mauro FR, Cerretti R, Anselmo AP, Mandelli F, Baroni CD. Hodgkin/Reed-Sternberg cells and Hodgkin's disease in patients with B-cell chronic lymphocytic leukaemia: an immunohistological, molecular and clinical study of four cases suggesting a heterogeneous pathogenetic background. Virchows Arch. 2000 Aug;437(2):129-32.
18. Mazet G. Presence d'elements alcoolo-acido-resistants dans les moelles leucemiques et les moelles non-leucemiques. Semaine des Hopitaux. 1962; No 1 et 2:35-38.
19. Carbone A. KSHV/HHV-8 associated Kaposi's sarcoma in lymph nodes concurrent with Epstein-Barr virus associated Hodgkin lymphoma. J Clin Pathol. 2005 Jun;58(6):626-8.
20. Wood C, Harrington W Jr. AIDS and associated malignancies. Cell Res. 2005 Nov-Dec;15(11-12):947-52.
21. Cantwell AR. Kaposi's sarcoma and variably acid-fast bacteria in vivo in two homosexual men. Cutis. 1983 Jul;32(1):58-61, 63-4, 68.
22. Cantwell AR. Necroscopic findings of variably acid-fast bacteria in a fatal case of acquired immunodeficiency syndrome and Kaposi's sarcoma. Growth. 1983 Summer;47(2):129-34.
23. Cantwell AR, Rowe L. African "eosinophilic bodies" in vivo in two American men with Kaposi's sarcoma and AIDS. J Dermatol Surg Oncol. 1985 Apr;11(4):408-12.
24. Cantwell AR. Mycobacterium avium-intracellulare infection and immunoblastic sarcoma in a fatal case of AIDS. Growth. 1986 Spring;50(1):32-40.
25. Aisenberg AC. Problems in Hodgkin's disease management.
Blood. 1999 Feb 1;93(3):761-79.
26. Travis LB, Hill D, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Pukkala E, Lynch CF, Pee D, Smith SA, Van't Veer MB, Joensuu T, Storm H, Stovall M, Boice JD Jr, Gilbert E, Gail MH. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst. 2005 Oct 5;97(19):1428-37.
26. Bowers DC, McNeil DE, Liu Y, Yasui Y, Stovall M, Gurney JG, Hudson MM, Donaldson SS, Packer RJ, Mitby PA, Kasper CE, Robison LL, Oeffinger KC. Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2005 Sep 20;23(27):6508-15.
27. Cantwell AR. Histologic observations of variably acid-fast pleomorphic bacteria in systemic sarcoidosis: a report of 3 cases. Growth. 1982 Summer;46(2):113-25.
28. Cantwell AR, Kelso DW, Jones JE. Histologic observations of coccoid forms suggestive of cell wall deficient bacteria in cutaneous and systemic lupus erythematosus. Int J Dermatol. 1982 Nov;21(9):526-37.
29. Cantwell AR, Cove JK. Variably acid-fast bacteria in a necropsied case of systemic lupus erythematosus with acute myocardial infarction. Cutis. 1984 Jun;33(6):560-7.
30. Cantwell AR, Craggs E, Wilson JW, Swatek F. Acid-fast bacteria as a possible cause of scleroderma. Dermatologica. 1968: 136;141-150.
31. Cantwell AR Jr. Histologic observations of pleomorphic, variably acid-fast bacteria in scleroderma, morphea, and lichen sclerosus et atrophicus. Int J Dermatol. 1984 Jan-Feb;23(1):45-52.
32. Mattman LH. Microbes and malignancy. In: Mattman LH. Cell Wall Deficient Forms; Stealth pathogens, 2nd ed. Boca Raton: CRC Press; 1993. pp. 311-321.
33. Young J. Description of an organism obtained from carcinomatous growths. Edinburgh Med J. 1921; 27:212-221.
34. Young J. An address on a new outlook on cancer: irritation and infection. Brit Med J. Jan 10, 1925, pp 60-64.
35. Scott MJ: The parasitic origin of carcinoma. Northwest Med. 1925;24:162-166.
36. Scott MJ: More about the parasitic origin of malignant epithelial growths. Northwest Med. 1925;25:492-498.
37. Nuzum JW. The experimental production of metastasizing carcinoma of the breast of the dog and primary epithelioma in man by repeated inoculation of a micrococcus isolated from human breast cancer. Surg Gynecol Obstet. 1925; 11;343-352.
38. Wuerthele Caspe (Livingston) V, Alexander-Jackson E, Anderson JA, et al. Cultural properties and pathogenicity of certain microorganisms obtained from various proliferative and neoplastic diseases. Amer J Med Sci. 1950; 220;628-646.
39. Alexander-Jackson E. A specific type of microorganism isolated from animal and human cancer: bacteriology of the organism. Growth. 1954 Mar;18(1):37-51.
40. Diller IC. Growth and morphological variability of pleomorphic, intermittently acid-fast organisms isolated from mouse, rat, and human malignant tissues. Growth. 1962; 26:181-209.
41. Diller IC, Diller WF. Intracellular acid-fast organisms isolated from malignant tissues. Trans Amer Micr Soc. 1965; 84:138-148.
Seibert FB, Feldmann FM, Davis RL, Richmond IS: Morphological, biological, and immunological studies on isolates from tumors and leukemic bloods. Ann N Y Acad Sci. 1970 Oct 30;174(2):690-728
42. Seibert FB, Yeomans F, Baker JA, Davis RL, Diller IC. Bacteria in tumors. Trans N Y Acad Sci. 1972 Jun;34(6):504-33.
43. Seibert FB, Farrelly FK, Shepherd CC. DMSO and other combatants against bacteria isolated from leukemia and cancer patients.Ann N Y Acad Sci. 1967 Mar 15;141(1):175-201.
44. Livingston (Wuerthele Caspe) V. Cancer, A New Breakthrough. Los Angeles: Nash Publishing Corp: Los Angeles; 1972.
45. Livingston-Wheeler VWC, Addeo E. The Conquest of Cancer. New York:Franklin Watts; 1984.
46. Cantwell A. The Cancer Microbe. Los Angeles: Aries Rising Press; 1990.
47. Cantwell A. Four Women Against Cancer. Los Angeles: Aries Rising Press; 2005.
48. Russell W. An address on a characteristic organism of cancer. Br Med J. 1890; 2:1356-1360.
49. Russell W. The parasite of cancer. Lancet. 1899;1:1138-1141.
50. Jetha N, Priddy RW. Exact nature of Russell bodies still an enigma. Am J Clin Pathol. 1984 Apr;81(4):545.
51. Dienes L. Morphology and reproductive processes of bacteria with defective cell wall. In, Guze LB (Ed), Microbial Protoplasts, Spheroplasts, and L Forms. Williams & Wilkins: Baltimore;1968. pp 74-93.
52. Cantwell AR. Histologic forms resembling "large bodies" in scleroderma and pseidoscleroderma. Am J Dermatopathol. 1980; 2:273-76.
53. Cantwell AR, Rowe L. African "eosinophilic bodies" in vivo in two American men with Kaposi's sarcoma and AIDS. J Dermatol Surg Oncol. 1985 Apr;11(4):408-12.
54. Livingston VWC, Livingston AM. Demonstration of Progenitor cryptocides in the blood of patients with collagen and neoplastic diseases. Trans NY Acad Sci. 1972; 174 (2):636-654.
55. Tedeschi GG, Sprovieri G, Del Prete P. Cocci and diphtheroids in blood cultures from patients in various pathological situations. Experientia. 1978 May 15; 3(5):59-68.
56. Tedeschi GG, Bondi A, Paparelli M, Sprovieri G. Electron microscopical evidence of the evolution of corynebacteria-like microorganisms within human erythrocytes. Experientia. 1978 Apr 15;34(4):458-60.
57. Domingue GJ, Schlegal JU, Woody HB, et al. Naked bacteria in human blood; a novel concept for etiology of certain kidney diseases. Microbia. 1976; 2:3-31.
58. McLaughlin RW, Vali H, Lau PC, Palfree RG, De Ciccio A, Sirois M, Ahmad D, Villemur R, Desrosiers M, Chan E. Are there naturally occurring pleomorphic bacteria in the blood of healthy humans? J Clin Microbiol. 2002 Dec;40(12):4771-5.
59. Parmley RT, Spicer SS, Pratt-Thomas HR, Morgan SK, Othersen HB. Microorganism-like structures in Hodgkin disease. Electron microscopical demonstration. Arch Pathol. 1975 May;99(5):259-66.
60. Sauter C, Kurrer MO. Intracellular bacteria in Hodgkin's disease and sclerosing mediastinal B-cell lymphoma: sign of a bacterial etiology? Swiss Med Wkly. 2002 Jun 15;132(23-24):312-5.
61. Sauter C, Blum S. Regression of lung lesions in Hodgkin's disease by antibiotics: case report and hypothesis on the etiology of Hodgkin's disease. Am J Clin Oncol. 2003 Feb;26(1):92-4.
62. Mattman LH, Tunstall LH, Mathews WW, et al. L variation in mycobacteria. Am Rev Resp Dis 1960; 174:852-861.
63. Mattman LH: Cell wall-deficient forms of mycobacteria. Ann N Y Acad Sci. 1970 Oct 30;174(2):852-61.
64. Csillag A. A simple method to obtain the mycococcus form of Mycobacterium phlei. J Gen Microbiol. 1970 Aug;62(2):251-9.
65. White MW. Plant bacterial spores, active systemically as a separate entity, play a significant role in human illnesses such as cancer, granulomas, AIDS, and milky white abdominal ascites that currently defies recognition. Med Hypotheses. 1995 Jun;44(6):493-503.